NRx Pharmaceuticals, Inc. (NRXP) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NRXP Revenue Growth
Revenue Breakdown (FY 2025)
NRXP's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
NRXP Revenue Analysis (2017–2025)
As of May 8, 2026, NRx Pharmaceuticals, Inc. (NRXP) generated trailing twelve-month (TTM) revenue of $242,000. The most recent quarter (Q3 2025) recorded $242,000 in revenue.
Looking at the longer-term picture, NRXP's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $1.2 million in 2025, representing a new all-time high.
Revenue diversification analysis shows NRXP's business is primarily driven by Therapy (100%). With over half of revenue concentrated in Therapy, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including AXSM (+63.9% YoY), ALTO (-4.9% YoY), and INMB (-100.0% YoY). Compare NRXP vs AXSM →
NRXP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NRXPCurrent | $242,000 | - | - | -1324.4% | |
 AXSM | $638M | +63.9% | - | -26.5% | |
 ALTO | $918M | -4.9% | +0.5% | 0.8% | |
 INMB | $50,000 | -100.0% | +35.4% | -61738.0% | |
 ATAI | $308,000 | +811.8% | - | -33341.2% |
NRXP Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.2M | - | $0 | - | $-16,224,000 | -1324.4% |
| 2024 | $0 | - | $-5,000 | - | $-19,704,000 | - |
| 2023 | $0 | - | $-5,000 | - | $-27,587,000 | - |
| 2022 | $0 | - | $-4,000 | - | $-44,335,000 | - |
| 2021 | $0 | - | $-2,000 | - | $-95,201,000 | - |
| 2020 | $0 | - | $-2,000 | - | $-22,061,000 | - |
| 2019 | $0 | - | $0 | - | $-713,187 | - |
| 2018 | $0 | - | $-1,006,503 | - | $-1,006,500 | - |
| 2017 | $0 | - | $0 | - | $0 | - |
See NRXP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NRXP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NRXP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNRXP — Frequently Asked Questions
Quick answers to the most common questions about buying NRXP stock.
Is NRXP's revenue growth accelerating or slowing?
NRXP TTM revenue: $242000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NRXP's long-term revenue growth rate?
NRx Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is NRXP's revenue distributed by segment?
NRXP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.